{"id":"NCT00443053","sponsor":"GlaxoSmithKline","briefTitle":"Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)","officialTitle":"An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5mg Subcutaneously) for the Treatment of Patients With Acute Symptomatic Isolated Superficial Thrombophlebitis of the Lower Limbs to Prevent Thromboembolic Complications","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2009-07","completion":"2009-07","firstPosted":"2007-03-05","resultsPosted":"2010-08-02","lastUpdate":"2017-03-06"},"enrollment":3002,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Thrombosis, Venous"],"interventions":[{"type":"DRUG","name":"Fondaparinux 2.5mg or placebo","otherNames":[]}],"arms":[{"label":"Fondaparinux 2.5mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.","primaryOutcome":{"measure":"Number of Participants With at Least on Event of Venous Thromboembolism (VTE) and/or Death From Any Cause Recorded up to Day 47","timeFrame":"Baseline to Day 47","effectByArm":[{"arm":"Fondaparinux 2.5 mg","deltaMin":13,"sd":null},{"arm":"Placebo","deltaMin":88,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":227,"countries":["Bulgaria","Czechia","Estonia","France","Germany","Greece","Hungary","Israel","Italy","Latvia","Netherlands","Poland","Russia","Slovakia","Spain","Switzerland","Ukraine"]},"refs":{"pmids":["23821661","20860504"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":1499},"commonTop":["Headache","Injection site hematoma","Hypertension","Asthenia"]}}